ArticleAging clinical and experimental research2021
SARC-F as a case-finding tool for sarcopenia according to the EWGSOP2. National validation and comparison with other diagnostic standards.
Article in Aging clinical and experimental research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04757454 (Performance Indicators of the SARC-F Questionnaire in Acute Care), which is not on this map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Performance Indicators of the SARC-F Questionnaire in Acute Care
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.
- Association and Prevalence of Lower Urinary Tract Symptoms in Individuals with Sarcopenia: A Systematic Review and Meta-Analysis.Medicina (Kaunas, Lithuania) · 2025Pooled it
- [Suspicion of sarcopenia as a predictor of toxicity in older people with cancer].Revista medica del Instituto Mexicano del Seguro Social · 2026Article
- Effects of early surgery (within 48 hours)Journal of thoracic disease · 2026Article
- Demographics, clinical features and outcomes of older patients presenting to an Irish emergency department.Irish journal of medical science · 2026Article
- Observational study on the comparability of the clinical profiles of older adults with hip fractures and pelvic fractures in Germany.Zeitschrift fur Gerontologie und Geriatrie · 2026Article
- Translation, Cross-Cultural Adaptation, and Validation of the Croatian Version of the SARC-F Questionnaire for Assessing Sarcopenia in Older Adults.Healthcare (Basel, Switzerland) · 2026Article
- Article
- Validation of Sarcopenic Obesity Screening Tools: A Cross-Sectional Analysis Based on ESPEN and EASO Criteria.Medicina (Kaunas, Lithuania) · 2025Article
- Phase angle is related to physical function in high-risk Dutch older adults: implications for sarcopenia screening.The Journal of frailty & aging · 2025Observational
- Prevalence of Sarcopenia Among Slovenian Older Adults and Associated Risk Factors.Zdravstveno varstvo · 2025Article
- Reliability and Clinical Validity of the SARC-Global Questionnaire for Sarcopenia and Sarcopenic Obesity in Spanish Older Adults.Nutrients · 2025Article
- SARC-F: an effective screening tool for detecting sarcopenia and predicting health-related quality of life in older women in Sri Lanka.BMC geriatrics · 2025Article
- Agreement analysis and associated factors of SARC-F and SARC-CALF in screening of risk sarcopenia in people living with human immunodeficiency virus.Clinics (Sao Paulo, Brazil) · 2025Article
- Performance Evaluation of Machine Learning Algorithms for Sarcopenia Diagnosis in Older Adults.Healthcare (Basel, Switzerland) · 2023Article
- Diminished Physical Activity in Older Hospitalised Patients with and without COVID-19.Journal of clinical medicine · 2023Article
- Article
- Diagnostic performance of SARC-F and SARC-CalF in screening for sarcopenia in older adults in Northern Brazil.Scientific reports · 2023Article
- Psychometric performance of the Kannada version of sarcopenia quality of life questionnaire (SarQoLBMC musculoskeletal disorders · 2023Article
- Sarcopenia and associated risk factors in oncology outpatients in specialized cancer centers in Saudi Arabia: a cross-sectional study.Annals of medicine and surgery (2012) · 2023Article
- Challenges in the Management of Sarcopenia in the Primary Care Setting: A Scoping Review.International journal of environmental research and public health · 2023Article
Corrections and comments
- Commented on by
Authors and funding
10 authors at 3 institutions in 3 countries.
Funding
Abstract
backgroundSarcopenia is a potentially reversible condition, which requires proper screening and diagnosis.
aimsTo validate a Polish version of sarcopenia screening questionnaire (SARC-F), and assess its clinical performance.
methodsCross-sectional validation study in community-dwelling subjects ≥ 65 years of age. Diagnosis of sarcopenia was based on the 2018 2nd European Working Group on Sarcopenia in Older People (EWGSOP2) consensus. Hand grip and 4-m gait speed were measured, and the Polish version of SARC-F was administered.
resultsThe mean (SD) age of 73 participants (21.9% men) was 77.8 (7.3) years. Seventeen participants (23.3%) fulfilled the EWGSOP2 criteria of sarcopenia, and 9 (12.3%) criteria for severe sarcopenia. Fourteen (19.2%) participants fulfilled the SARC-F criteria for clinical suspicion of sarcopenia. The Cronbach's alpha coefficient for internal was 0.84. With EWGSOP2 sarcopenia as a gold standard, the sensitivity of SARC-F was 35.3% (95% CI 14.2-61.7, p = 0.33), specificity was 85.7% (95% CI 73.8-93.6, p < 0.0001). The corresponding positive and negative predictive values were 42.9% (p = 0.79) and 81.4% (p < 0.0001), respectively. The probability of false-positive result was 14.3% (95% CI 6.4-26.2, p < 0.0001) and the probability of false-negative result was 64.7% (95% CI 38.3-85.8, p = 0.33). Overall the predictive power of SARC-F was low (c-statistic 0.64). DISCUSSION: SARC-F is currently recommended for sarcopenia case finding in general population of older adults. However, its sensitivity is low, despite high specificity.
conclusionsAt present SARC-F is better suited to rule out sarcopenia then to case-finding. Further refinement of screening for sarcopenia with the use of SARC-F seems needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.